BioMarin Pharmaceutical | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 3.38B 111M 2024-12
Bayer EUR 1.83B 2.31B 2025-03
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
Incyte USD 558.01M 323.82M 2025-06
Insmed USD -255671000 21.39M 2025-03
Ionis Pharmaceuticals USD 124M 271M 2025-06
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 408.4M 15.1M 2025-06
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12


BioMarin Pharmaceutical Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.